|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Julie Phillips, Marketing Manager
Email: julie.phillips@terrapinn.com
Tel: 02075394336
Fax: 02072421508
|
Genetic Engineering and Biotechnology News (GEN) is the longest-running, most widely read, and largest circulated global biotechnology news publication. Published 21 times a year and recently redesigned to focus on Biobusiness, OMICS, Drug Discovery, Bioprocessing, and Translational Medicine, GEN reports on key news developments and technology trends in the bioindustry.
EUROPEAN BIOTECHNOLOGY Science & Industry News:
The attractive information environment of this monthly published magazine constitutes of thoroughly researched news from science and industry, background reports on new EU legislation, current debates and financing initiatives from Brussels, as well as market analyses on the strengths and weaknesses of European biotech nations and previews on upcoming technology trends. With the European Biotechnology News journal you can address a competent an specialized readership in all 25 EU member states, as well as in Switzerland and Norway, predominantly in the major biotech clusters, in renowned European research institutions, as well as the current members of the 13 national scientific and corporate associations and readers in the biotechnology and Life Sciences industry sector.
BioWorld Europe is an innovative magazine for Life Science clusters, commercial and not-for-profit organisations. Its mission is to provide decision-makers in the European biotech industry with thoroughly compiled news, comprehensive background of recent developments, and practical management resources.
BioWorld Europe is pure B2B-communication. It is unique in providing both, an overview on a specific topic – the editorial focus – and in depth coverage on a determined biotech hot spot – the regional focus (see editorial calendar below). Up to two thirds of the magazines total editorial content is dedicated to these specified focus areas.
Thus, current research and technology is related to the people, the organisations and their places. This guarantees for readers, sponsors and advertisers alike that each issue has a high informative value. This value is maximized with an efficiently targeted distribution: each single issue is adjusted to the markets’ needs!
Thomson Pharma was developed to help pharmaceutical companies make better decisions faster.
It integrates information from Thomson Scientific with information from other Thomson sources, including the Financial, Healthcare and Legal and Regulatory groups. Thomson Pharma's core content areas include drug information, intellectual property data, literature and news, company data, chemical information, sequence data and drug target information, enhanced with value added content resources and powerful search tools. www.thomsonpharma.com
SCREENING - Trends in Drugs Discovery focuses new trends and developments in drug discovery. SCREENING covers all aspects of research as well as strategies of pharmaceutical companies and start-up companies. This editorial mixture makes for relevant reading for all those concerned with drug discovery. SCREENING - Trends in Drugs Discovery is published in English with 4 editions in 2006. For more information please contact Dr. Jutta van Empel at j.empel@gitverlag.com or tel. +49 6151 8090-139.
Published by Espicom Business Intelligence, Neuro Drug Focus will keep you fully updated with the latest developments in neurodegenerative product registration, agreements and clinical trials. In addition, Neuro Drug Focus summarises key research presented at international conferences and in journals, and features special articles focusing on companies or topics that are influencing this sector.
For full details or to download a sample issue please visit www.espicom.com/ndfsub
Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries.
Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work
Expert Review of Neurotherapeutics provides a centralized resource that will inform decision-making in research, clinical practice and cost-effective healthcare.
“Expert Review of Neurotherapeutics provides up to the minute, highly authoritative, and very useful information on the rapidly growing area of treatment of neurological disorders.”
Daniel Tarsy, Beth Israel Deaconess Medical Center, USA
For more information go to www.future-drugs.com or email info@future-drugs.com
Drug Discovery Today is one of the most cited review journals in the field of drug discovery. Since its launch in 1996, it continues to publish reviews of key scientific and strategic issues as well as features, such as opinionated Editorials, interviews with international experts and business trends. Drug Discovery Today covers not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Drug Discovery Today is published monthly in print and digital editions and updated daily on-line on ScienceDirect. Our current ISI impact factor is 7.7.
In 2004, the Drug Discovery Today journal series expanded with the launch of four online-only review journals: Drug Discovery Today: Disease Mechanisms, Drug Discovery Today: Disease Models, Drug Discovery Today: Therapeutic Strategies and Drug Discovery Today: Technologies.
In 2006, Drug Discovery Today launched a digital edition of its magazine. This has allowed us to incorporate new media technology, including videos, animations and sound, all designed to enhance the readers experience.
For more information on Drug Discovery Today please visit our website www.drugdiscoverytoday.com.
www.drugdevelopment-technology.com is used by professionals within the drug development industry as means of creating partnerships and as a key point of reference. This comprehensive resource supplies detailed information on drugs under development and in production, breakdowns of leading drug development companies and suppliers, alongside the latest developments, products and services.
Professionals from around the world use www.drugedevelopment-technology.com to keep abreast of the latest developments and use our resources to make informed decisions. Resources such as free white papers and press releases from the leading drug development companies, comprehensive events listings and much, much more.
Bentham Science Publishers, a major STM journal publisher of over 70 titles in 2006, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Pharmaceutical Design (Impact Factor 5.38):
FREE online journals and information: www.bentham.org
Subscribe, Consortia, discounted global licenses and trials: subscriptions@bentham.org
DrugResearcher.com is the leading B2B strategic news resource for the drug discovery market, providing key decision makers and industry professionals with the crucial market intelligence and latest breaking news across Europe, America and Asia Pacific. Subscribe now for the FREE e-newsletter of this complete information source within the pharmaceutical industry.
|
|
|
|
